• Product NameThalidomide
• Brief DescriptionInhibitors
• Purification98.88%
• Biological ActivityThalidomide can directly inhibit angiogenesis induced by bFGF or VEGF in vivo.
• Target NameTNF inhibitor
• CAS No. 50-35-1
• Calculated MW 258.23
• Formulation C13H10N2O4
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12
  Pathways:Apoptosis
  Receptor:TNF-α
  Boling pt:
  Melting pt:269-271C
  Solubility:Ethanol: 2 mg/mL (7.74 mM); DMSO: 52 mg/mL (201.37 mM)
  Appearance:White Crystal
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Zhu YX, et al. Leuk Lymphoma. 2013 Apr;54(4):683-7.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting